25-hydroxycholesterol has been researched along with Atherogenesis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Broncel, M; Gorzelak-Pabiś, P; Pawlos, A; Wojdan, K; Woźniak, E | 1 |
| Andrés-Blasco, I; Canfrán-Duque, A; Fernández-Fuertes, M; Fernández-Hernando, C; Fowler, JW; Giannarelli, C; Gómez-Coronado, D; McDonald, JG; Price, NL; Rotllan, N; Schneider, RJ; Sessa, WC; Suárez, Y; Sun, J; Tellides, G; Thompson, BM; Zhang, X | 1 |
| Kotelevtsev, Y; Lathe, R; Sapronova, A | 1 |
| Honda, A; Igarashi, M; Ishibashi, S; Kumagai, M; Nagashima, S; Ohshiro, T; Okazaki, H; Osuga, J; Sakai, K; Sekiya, M; Takahashi, M; Tomoda, H; Yagyu, H; Yamamuro, D | 1 |
| Bartling, B; Buerke, M; Ebelt, H; Fu, H; Gielen, S; Großmann, J; Hiebl, B; Hofmann, B; Jaschke, C; Koch, S; Larisch, M; Loppnow, H; Müller-Werdan, U; Pilowski, C; Riemann, D; Schlecht, K; Schlitt, A; Seliger, B; Silber, RE; Simm, A; Spieler, F; Unverzagt, S; Werdan, K | 1 |
| Geng, YJ; Rosales, C; Tang, D | 1 |
| Arai, H; Hamakubo, T; Kodama, T; Morita, M; Nishimura, T; Noguchi, N; Sekine, A; Takabe, W; Urano, Y | 1 |
| Alejandre, MJ; Linares, A; Morales, RP; Perales, S; Torres, C | 1 |
| Gu, J; Li, J; Liu, F; Wang, F; Wang, G; Xia, W | 1 |
| Aderem, A; Gold, ES; Moritz, RL; Podolsky, I; Ramsey, SA; Rodriguez, DJ; Sartain, MJ; Selinummi, J | 1 |
| Dijkstra, MH; Gurzeler, E; Heinonen, SE; Jauhiainen, S; Kivelä, AM; Levonen, AL; Ylä-Herttuala, S | 1 |
| Li, D; Mehta, JL | 1 |
1 review(s) available for 25-hydroxycholesterol and Atherogenesis
| Article | Year |
|---|---|
Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atherosclerosis; Brain; Humans; Hydroxycholesterols; Inflammation; Inflammation Mediators | 2014 |
11 other study(ies) available for 25-hydroxycholesterol and Atherogenesis
| Article | Year |
|---|---|
Expression of anti and pro-inflammatory genes in human endothelial cells activated by 25-hydroxycholesterol: A comparison of rivaroxaban and dabigatran.
Topics: Administration, Oral; Anticoagulants; Atherosclerosis; Atrial Fibrillation; Cytokines; Dabigatran; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Interleukin-18; Interleukin-23; Oxysterols; Rivaroxaban; RNA, Messenger; Transforming Growth Factor beta | 2022 |
Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling.
Topics: Animals; Atherosclerosis; Cholesterol; Humans; Hydroxycholesterols; Inflammation; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic | 2023 |
Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Apoptosis; Atherosclerosis; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Hydroxycholesterols; Macrophages, Peritoneal; Mice; Mice, Knockout; Signal Transduction; Sterol Esterase; Transcription Factor CHOP | 2014 |
Interleukin-1 potently contributes to 25-hydroxycholesterol-induced synergistic cytokine production in smooth muscle cell-monocyte interactions.
Topics: Atherosclerosis; Blotting, Western; Cells, Cultured; Chemokine CCL2; Coculture Techniques; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxycholesterols; Immunity, Innate; Inflammation; Interleukin-1beta; Interleukin-6; Monocytes; Myocytes, Smooth Muscle; Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2014 |
CD1d serves as a surface receptor for oxidized cholesterol induction of peroxisome proliferator-activated receptor-γ.
Topics: Animals; Antigens, CD1d; Atherosclerosis; Cell Membrane; Cholesterol; DNA Primers; HEK293 Cells; Humans; Hydroxycholesterols; Immunoglobulin G; Ketocholesterols; Lipids; Macrophages; Mice; Mice, Knockout; Microscopy, Fluorescence; Oxygen; PPAR gamma; Protein Binding; Sterols | 2015 |
Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells.
Topics: Active Transport, Cell Nucleus; Atherosclerosis; Biological Transport; Carbon Radioisotopes; Cell Membrane; Cell Nucleus; Cells, Cultured; Cholesterol; Down-Regulation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Interleukin-6; Interleukin-8; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Sterol Regulatory Element Binding Protein 2; Up-Regulation | 2015 |
Fish oil supplementation reverses the effect of cholesterol on apoptotic gene expression in smooth muscle cells.
Topics: Animals; Annexin A5; Aorta, Thoracic; Apoptosis; Apoptosis Regulatory Proteins; Atherosclerosis; Caspase 3; Cells, Cultured; Chickens; Cholesterol, Dietary; Diet, Atherogenic; Dietary Supplements; Fish Oils; Foam Cells; Gene Expression Regulation; Hydroxycholesterols; Male; Myocytes, Smooth Muscle; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tumor Suppressor Protein p53 | 2010 |
Interferon regulator factor 1/retinoic inducible gene I (IRF1/RIG-I) axis mediates 25-hydroxycholesterol-induced interleukin-8 production in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Base Sequence; Chemokine CXCL1; DEAD Box Protein 58; DEAD-box RNA Helicases; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Interferon Regulatory Factor-1; Interleukin-8; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Immunologic; RNA, Small Interfering; Signal Transduction | 2012 |
ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation.
Topics: Activating Transcription Factor 3; Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Female; Hydroxycholesterols; Lipid Metabolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Promoter Regions, Genetic; Steroid Hydroxylases | 2012 |
Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Topics: Adenoviridae; Animals; Apolipoprotein B-100; Atherosclerosis; Binding Sites; Blotting, Western; Cells, Cultured; Cholesterol, HDL; Chromatin Immunoprecipitation; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Vectors; Human Umbilical Vein Endothelial Cells; Humans; Hydroxycholesterols; Lipase; Mice; Mice, Knockout; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, LDL; RNA Interference; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Time Factors; Transfection; Vascular Endothelial Growth Factor A | 2012 |
Oxidized LDL, a critical factor in atherogenesis.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biomarkers; Cholesterol; DNA-Binding Proteins; Down-Regulation; Endothelium, Vascular; Homeostasis; Humans; Hydroxycholesterols; Lipoproteins, LDL; Liver X Receptors; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Scavenger Receptors, Class E | 2005 |